Multi-functional nanogels for tumor targeting and redox-sensitive drug and siRNA delivery
- Authors: Adamo, G; Grimaldi, N; Campora, S; Bulone, D; Bondi, ML; Al-Sheikhly, M; Sabatino, MA; Dispenza, C; Ghersi, G;
- Publication year: 2016
- Type: Articolo in rivista (Articolo in rivista)
- Key words: Doxorubicin; e-beam; Folate-targeting; GSH-responsive release; Nanogels; PVP; siRNA;
- OA Link: http://hdl.handle.net/10447/215973
Abstract
(1) Background: A new family of nanosystems able to discern between normal and tumor cells and to release a therapeutic agent in controlled way were synthetized by e-beam irradiation. This technique permits to obtain biocompatible, sterile, carboxyl-functionalized polyvinylpyrrolidone (PVP-co-acrylic acid) nanogels (NGs); (2) Methods: Here, we performed a targeting strategy based on the recognition of over-expressed proteins on tumor cells, like the folate receptor. The selective targeting was demonstrated by co-culture studies and flow cytometry analysis, using folate conjugated NGs. Moreover, nanoparticles were conjugated to a chemotherapeutic drug or to a pro-apoptotic siRNA through a glutathione sensitive spacer, in order to obtain a controlled release mechanism, specific for cancer cells. The drug efficiency was tested on tumor and healthy cells by flow cytometric analysis, confocal and epifluorescence microscopy and cytotoxicity assay; the siRNA effect was investigated by RNAi experiment; (3) Results: The data obtained showed that the use of NGs permits a faster cargo release in cancer cells, in response to high cytosolic glutathione level, also improving their efficacy; (4) Conclusion: The possibility of releasing biological molecules in a controlled way and to recognize a specific tumor target allows overcoming the typical limits of the classic cancer therapy.